跳转至内容
Merck
CN
  • Oral Bacitracin: A Consideration for Suppression of Intestinal Vancomycin-Resistant Enterococci (VRE) and for VRE Bacteremia From an Apparent Gastrointestinal Tract Source.

Oral Bacitracin: A Consideration for Suppression of Intestinal Vancomycin-Resistant Enterococci (VRE) and for VRE Bacteremia From an Apparent Gastrointestinal Tract Source.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2015-02-24)
Truc T Tran, Hannah R Palmer, Marion R Weimar, Cesar A Arias, Gregory M Cook, Barbara E Murray